Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through PIK3IP1-PI3K/AKT Axis in Acute Myeloid Leukemia

被引：0

作者：

Yang, Chan ^{[1
]}

Zi, Jie ^{[1
]}

Song, Chunhua ^{[2
]}

Ge, Zheng ^{[1
]}

机构：

[1] Southeast Univ, Inst Hematol Southeast Univ, Sch Med, Zhongda Hosp, Nanjing, Peoples R China

[2] Ohio State Univ, Coll Med, Hershey, PA USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-152796

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3345

引用

页数：4

共 50 条

[41] Odorant Stimulation Promotes Survival of Rodent Olfactory Receptor Neurons via PI3K/Akt Activation and Bcl-2 Expression
Kim, So Yeun
Yoo, Seung-Jun
Ronnett, Gabriele V.
Kim, Eun-Kyoung
Moon, Cheil
MOLECULES AND CELLS, 2015, 38 (06) : 535 - 539
[42] LINC00665 Induces Acquired Resistance to Gefitinib through Recruiting EZH2 and Activating PI3K/AKT Pathway in NSCLC
Liu, Xinyin
Lu, Xiyi
Zhen, Fuxi
Jin, Shidai
Yu, Tongfu
Zhu, Quan
Wang, Wei
Xu, Kun
Yao, Jiaqi
Guo, Renhua
MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 155 - 161
[43] GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2
He, Junbo
Wang, Liangzhi
Lv, Mengjia
Yuan, Yiming
DISCOVER ONCOLOGY, 2025, 16 (01)
[44] β-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways
Moon, Dong-Oh
Kim, Mun-Ock
Choi, Yung Hyun
Kim, Gi-Young
CANCER LETTERS, 2008, 264 (02) : 181 - 191
[45] ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
Rehman, Hasibur
Chandrashekar, Darshan S.
Balabhadrapatruni, Chakravarthi
Nepal, Saroj
Balasubramanya, Sai Akshaya Hodigere
Shelton, Abigail K.
Skinner, Kasey R.
Ma, Ai-Hong
Rao, Ting
Agarwal, Sumit
Eich, Marie-Lisa
Robinson, Alyncia D.
Naik, Gurudatta
Manne, Upender
Netto, George J.
Miller, C. Ryan
Pan, Chong-Xian
Sonpavde, Guru
Varambally, Sooryanarayana
Ferguson, James E., III
JCI INSIGHT, 2022, 7 (16)
[46] Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
Hui Liang
Qi-Li Zheng
Peng Fang
Jian Zhang
Tuo Zhang
Wei Liu
Min Guo
Christopher L. Robinson
Shui-bing Chen
Xiao-Ping Chen
Fang-Ping Chen
Hui Zeng
Scientific Reports, 7
[47] Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia
Zeng, Zhihong
Maiti, Abhishek
Herbrich, Shelley
Cai, Tianyu
Cavazos, Antonio
Manzella, Taylor
Ma, Helen
Hayes, Kala
Matthews, Jairo
DiNardo, Courtney D. D.
Daver, Naval G. G.
Konopleva, Marina Y. Y.
CANCER, 2023, 129 (04) : 531 - 540
[48] Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
Liang, Hui
Zheng, Qi-Li
Fang, Peng
Zhang, Jian
Zhang, Tuo
Liu, Wei
Guo, Min
Robinson, Christopher L.
Chen, Shui-bing
Chen, Xiao-Ping
Chen, Fang-Ping
Zeng, Hui
SCIENTIFIC REPORTS, 2017, 7
[49] mTORC1 Activity Is Independent of PI3K/Akt but Controlled by AMPK in Acute Myeloid Leukemia
Green, Alexa Samantha
Tamburini, Jerome
Willems, Lise
Chapuis, Nicolas
Park, Sophie
Bardet, Valerie
Foretz, Marc
Viollet, Benoit
Ifrah, Norbert
Dreyfus, Francois
Mayeux, Patrick
Lacombe, Catherine
Bouscary, Didier
BLOOD, 2008, 112 (11) : 345 - 346
[50] BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
Alford, Sarah E.
Kotharil, Anisha
Loeff, Floris C.
Eichhorn, Joshua M.
Sakurikar, Nandini
Goselink, Henriette M.
Saylors, Robert L.
Jedema, Inge
Falkenburg, J. H. Frederik
Chambers, Timothy C.
CANCER RESEARCH, 2015, 75 (07) : 1366 - 1375

← 1 2 3 4 5 →